Long-term study of ME2112 in patients with schizophrenia (Phase III)
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Meiji Seika Pharma
- 08 Jun 2016 New trial record